ArriVent BioPharma, Inc. (NASDAQ:AVBP) IPO
IPO
Priced at US$18.00 a share on Jan 25, 2024.
- Price
- US$18.00 a share
- Shares offered
- 9,722,222 shares of common stock
- Offering size
- US$175 million
- Underwriters' option
- Up to 1,458,333 more shares
- Listing
- AVBP on the Nasdaq Global Market
- Underwriters
- Goldman Sachs & Co. LLC, Jefferies, Citigroup, LifeSci Capital · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 25, 2023 |
| Filed publicly | Jan 5, 2024 |
| Amended twice | Newest Jan 23, 2024 |
| Shares registered with an exchange | Jan 23, 2024 |
| Declared effective by the SEC | Jan 25, 2024 |
| Final prospectus, with the price | Jan 26, 2024 |
Filings
From the cover of the final prospectus (424B4) filed Jan 26, 2024